Literature DB >> 17466303

Reducing maternal mortality due to elective abortion: Potential impact of misoprostol in low-resource settings.

C C Harper1, K Blanchard, D Grossman, J T Henderson, P D Darney.   

Abstract

Over 99% of deaths due to abortion occur in developing countries. Maternal deaths due to abortion are preventable. Increasing the use of misoprostol for elective abortion could have a notable impact on maternal mortality due to abortion. As a test of this hypothesis, this study estimated the reduction in maternal deaths due to abortion in Africa, Asia and Latin America. The estimates were adjusted to changes in assumptions, yielding different possible scenarios of low and high estimates. This simple modeling exercise demonstrated that increased use of misoprostol, an option for pregnancy termination already available to many women in developing countries, could significantly reduce mortality due to abortion. Empirical testing of the hypothesis with data collected from developing countries could help to inform and improve the use of misoprostol in those settings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17466303     DOI: 10.1016/j.ijgo.2007.03.009

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  15 in total

1.  The potential of medical abortion to reduce maternal mortality in Africa: what benefits for Tanzania and Ethiopia?

Authors:  Rebecca F Baggaley; Joanna Burgin; Oona M R Campbell
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

2.  Sexual and reproductive health: progress and outstanding needs.

Authors:  Rachel C Snow; Laura Laski; Massy Mutumba
Journal:  Glob Public Health       Date:  2015-01-02

3.  Hospital admission following induced abortion in Eastern Highlands Province, Papua New Guinea--a descriptive study.

Authors:  Lisa M Vallely; Primrose Homiehombo; Angela Kelly-Hanku; Antonia Kumbia; Glen D L Mola; Andrea Whittaker
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

4.  A harm-reduction model of abortion counseling about misoprostol use in Peru with telephone and in-person follow-up: A cohort study.

Authors:  Daniel Grossman; Sarah E Baum; Denitza Andjelic; Carrie Tatum; Guadalupe Torres; Liza Fuentes; Jennifer Friedman
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

5.  Incidence of induced abortion in Malawi, 2015.

Authors:  Chelsea B Polis; Chisale Mhango; Jesse Philbin; Wanangwa Chimwaza; Effie Chipeta; Ausbert Msusa
Journal:  PLoS One       Date:  2017-04-03       Impact factor: 3.240

6.  Medical Abortion Provision by Pharmacies and Drug Sellers in Low- and Middle-Income Countries: A Systematic Review.

Authors:  Katharine Footman; Katherine Keenan; Kate Reiss; Barbara Reichwein; Pritha Biswas; Kathryn Church
Journal:  Stud Fam Plann       Date:  2018-03

Review 7.  Latin American women's experiences with medical abortion in settings where abortion is legally restricted.

Authors:  Nina Zamberlin; Mariana Romero; Silvina Ramos
Journal:  Reprod Health       Date:  2012-12-22       Impact factor: 3.223

8.  Self-administered versus provider-administered medical abortion.

Authors:  Katherine Gambir; Caron Kim; Kelly Ann Necastro; Bela Ganatra; Thoai D Ngo
Journal:  Cochrane Database Syst Rev       Date:  2020-03-09

Review 9.  Facility-based treatment for medical complications resulting from unsafe pregnancy termination in the developing world, 2012: a review of evidence from 26 countries.

Authors:  S Singh; I Maddow-Zimet
Journal:  BJOG       Date:  2015-08-19       Impact factor: 6.531

10.  Relationship of family formation characteristics with unsafe abortion: is it confounded by women's socio-economic status? - A case-control study from Sri Lanka.

Authors:  Carukshi Arambepola; Lalini C Rajapaksa; Deepika Attygalle; Loshan Moonasinghe
Journal:  Reprod Health       Date:  2016-06-17       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.